Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Maintenance Therapy with Aromatase Inhibitor in epithelial Ovarian Cancer (MATAO): study protocol of a randomized double-blinded placebo-controlled multi-center phase III Trial

Fig. 3

Envisioned results on a feeling and energy scale during maintenance phase, after at least 4 cycles of chemotherapy and potential surgery, determined via questionnaires and objectified via activity tracker. EQ-5D   European Quality of Life Scale, 5-Dimensions, FACT-ES   Functional Assessment of Cancer Therapy—Endocrine subscale, FACT-0   Functional Assessment of Cancer Therapy – Ovarian cancer symptoms subscale, PFS   Progression Free Survival

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us